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Improved understanding of the interplay between
host and microbes stands to illuminate new avenues
for disease diagnosis, treatment, and prevention.
Here, we provide a high-resolution view of the dy-
namics between host and gut microbiota during
antibiotic-induced intestinal microbiota depletion,
opportunistic Salmonella typhimurium and Clos-
tridium difficile pathogenesis, and recovery from
these perturbed states in a mouse model. Host-
centric proteome and microbial community profiles
provide a nuanced longitudinal view, revealing the
interdependence between host and microbiota in
evolving dysbioses. Time- and condition-specific
molecular and microbial signatures are evident and
clearly distinguished from pathogen-independent in-
flammatory fingerprints. Our data reveal that mice
recovering from antibiotic treatment or C. difficile
infection retain lingering signatures of inflammation,
despite compositional normalization of the micro-
biota, and host responses could be rapidly and
durably relieved through fecal transplant. These ex-
periments demonstrate insights that emerge from
the combination of these orthogonal, untargeted
approaches to the gastrointestinal ecosystem.INTRODUCTION
Antibiotic-associated diarrhea occurs in 5%–25% of patients
treated with antibiotics and causes thousands of deaths and bil-
lions of dollars of additional costs to the health care industry
each year (Bergogne-Be´re´zin, 2000). The general mechanism
behind the pathogenesis of these diseases is well understood:
broad-spectrum antibiotics deplete the commensal gastrointes-
tinal (GI) microbiota and allow pathogens to colonize and prolif-
erate (Ho¨genauer et al., 1998). Once established in GI niches,
pathogens can harm the host through multiple mechanisms.
The antibiotic-associated pathogenic bacteria Salmonella tyhpi-
murium andClostridium difficile cause GI dysbioses through two
distinct mechanisms. Salmonella is an intracellular pathogen,Cell Rinvading intestinal cells via a type-3 secretion system (Ohl and
Miller, 2001) and promoting intestinal permeability. In contrast,
C. difficile remains extracellular but, instead, secretes toxin pro-
teins that are endocytosed by intestinal epithelia, causing
apoptotic cell death (Nam et al., 2010).
Despite these explicit mechanisms of infection, the systems-
wide effects on the host and microbiota within the GI tract are
poorly understood. Global microbial responses to, and recovery
from, antibiotics have been clearly demonstrated using unbiased
community profiling approaches (Dethlefsen and Relman, 2011),
but without a similarly objective metric to measure host re-
sponses, a comprehensive view of the ecosystem has remained
out of reach. Anti-microbial peptides (Cash et al., 2006), immu-
noglobulins (Suzuki and Fagarasan, 2008), and mucin proteins
(Martens et al., 2008) all respond to and directly interact with
themicrobiota, protecting the host from commensal or pathogen
outgrowth. The longitudinal and long-term effects of microbiota
disturbance, pathogen invasion, intestinal inflammation, and re-
covery on these and other yet-to-be-discovered interactions
remain unknown.
The intestinal microbiota is inherently variable across individ-
uals and between biological states. This variability complicates
efforts to draw direct and meaningful comparisons between
any two states using genomic technologies (Costello et al.,
2009). Conversely, the host genome is essentially invariant
over experimental time frames and is generally better defined
than microbial metagenomes. Furthermore, proteins expressed
by the single host genome stand to directly reflect how changing
conditions impact the host and its influence on the microbiome.
Thus, focused attention on intestinally expressed host proteins
promote robust and readily interpretable comparisons across
experimental states. Toward this end, we recently developed
an untargeted, mass-spectrometry-based proteomics approach
to measure GI host responses to the microbiota (Lichtman et al.,
2013). By applying a ‘‘host-centric’’ strategy of stool proteomics
to multiple mouse and human microbial states, we showed that
the relative abundances of hundreds of host-derived fecal pro-
teins serve as a sensitive fingerprint of gut homeostasis from
the perspective of the host. With this method, we also evaluated
howwide-ranging changes to themicrobiota impacts host phys-
iology across distinct GI tract regions (Lichtman et al., 2015).
In the present study, we applied the ‘‘host-centric proteomics
of stool’’ method to fecal specimens collected from mice in
a time-course fashion. This experimental model provided aeports 14, 1049–1061, February 9, 2016 ª2016 The Authors 1049
non-invasive avenue for learning how antibiotic disruption im-
pacts host biology and promotes pathogenesis. Our analysis
provides orthogonal insights into antibiotic-associated diseases
learned from combined host- and microbe-centric analyses.
Multi-dimensional host protein profiles provided a high-resolu-
tion view of gut perturbation and the dynamics of recovery.
Considered in combination with microbial enumeration, they
led to the following principal conclusions: (1) an antibiotic cock-
tail followed by clindamycin treatment induced a far more dura-
ble disruption to the host proteome than streptomycin, despite
promoting similar global perturbations to the microbiota; (2) the
host proteome reflects clear signatures of sub-pathological Sal-
monella colonization; (3) condition-specific signatures of host
inflammation, whether pathogen dependent or independent,
are apparent from the host proteome; and (4) inflammatory sig-
natures in host responses persist after pathogen clearance and
microbiota recovery yet can be immediately normalized by fecal
transplantation. Through these investigations, we demonstrate
that the host is an essential and dynamic component in modu-
lating changes to highly complex microbiome systems.
RESULTS
To examine the effects of antibiotics and antibiotic-associated
infection on the host-microbiota dynamic, we initiated two
distinct infection models in mice, Salmonella typhimurium (Sal-
monella) andClostridium difficile (C. difficile) (Figure S1). In these
established models, streptomycin promotes the expansion of
Salmonella, causing a terminal infection; a cocktail of antibiotics
followed by a single dose of clindamycin allows for the emer-
gence of C. difficile, from which the host can recover (Ng et al.,
2013). We tracked the microbiota and host proteome of individ-
ual mice from their conventional state, through antibiotic treat-
ment, pathogen infection, and, in the case ofC. difficile, recovery
aided by fecal transplant. In total, we assessed the microbiota
and host proteome of 37 animals distributed across 11 condi-
tions and 16 time points. The coincident dynamics of over 100
microbial taxa (operational taxonomic units; OTUs) and 1,425
host proteins allowed us to directly interrogate interdepen-
dencies between the host and microbiota.
Differential Antibiotic RecoveryDynamics betweenHost
Proteome and Microbiota
Antibiotics are a necessary step toward initiating many enteric
diseases, but even broad-spectrum antibiotics such as strepto-
mycin and clindamycin can have differing effects on microbiota
subpopulations (Sekirov et al., 2008). Therefore, we sought to
first compare the extent to which these antibiotic treatments
caused lasting changes to host and microbiota in ways that
could promote pathogen colonization, as measured by 16S
rRNA microbial community profiling and host-centric prote-
omics. Conventional mice were treated with either streptomycin
or a combination of an antibiotic cocktail and clindamycin (see
Experimental Procedures), and fecal samples were collected
for 4 days after treatment (Figure 1A). As expected, alpha diver-
sity, a metric for the complexity of the microbial community,
decreased by more than 2-fold in both antibiotic-treated condi-
tions (Figure 1B). In both cases, the diversity of themicrobiota re-1050 Cell Reports 14, 1049–1061, February 9, 2016 ª2016 The Authomained 2-fold decreased by the fourth day after treatment (Fig-
ure 1B), and the microbiota composition remained perturbed as
measured by principal-component analysis (PCA) (Figures S2A
and S2B). Of 123 significantly changing (adjusted p < 0.01)
OTUs grouped by microbial family (Table S1), the two taxa
most negatively affected by both antibiotic treatments were
undefined members of the Bacteroidales (average, 35-fold) and
undefined members of the Clostridiales (average, 19-fold) (Fig-
ure 1C). Other taxa were differentially affected by the two antibi-
otics: 1 day following treatment, streptomycin-treated mice
exhibited an average 32-fold increase in Ruminococcaceae,
whereas mice treated with clindamycin exhibited a bloom in
Enterobaceriaceae (115-fold) and Enterococcaceae (32-fold)
(Figure 1C). By 4 days post-treatment, the increases in Rumino-
coccaceae, Enterobacterieacea, and Enterococcaceae had
resolved, returning to their original relative abundances, while
the unclassified Bacteroidales and Clostridiales groups re-
mained significantly decreased (Figure 1C). In both treatment
conditions, members of the Bacteroidaceae family bloomed on
day 4 post-treatment (Figure 1C). These data confirm that
several types of bacteria are able to survive antibiotic treatment,
which alters their apparent relative abundances over short time-
scales. Our findings show that these two broad-spectrum antibi-
otics made similar global alterations to the microbiota but with
idiosyncratic opportunistic outgrowths of individual taxa. Next,
we examined whether these changes to the microbiota were
associated with changes in the host protein expression.
Host fecal proteomes provided us with an orthogonal dimen-
sion for evaluating antibiotic-induced perturbations. We identi-
fied an average of 6,616 spectra mapping to 326 proteins per
fecal sample collected from each mouse at each time point
and treatment condition. Proteins were quantitatively compared
between each condition using normalized spectral counts,
which span 4 orders of magnitude of dynamic range. These
data exhibited distinct temporal dynamics from the microbiota
and served as state-specific fingerprints used for PCA. The
day following each antibiotic treatment, host proteomes coa-
lesced into a single state, distinct from untreated animals (Fig-
ures 1D and 1E). Throughout the 4-day time course, host
proteomes measured from clindamycin-treated mice retained
proteomic profiles that were distinct from those of untreated
mice and consistent with the pronounced perturbation observed
on days 1 and 2 (Figure 1E). These dynamics mimic the effects of
clindamycin on microbiota complexity (Figure 1B). Conversely,
streptomycin-treated mice returned to a proteome state indistin-
guishable from that of the conventional mice by day 4, even
though the microbiota diversity remained depleted (Figures 1B
and 1D). The observation that only streptomycin-treated host
proteomes recovered to a conventional state while the micro-
biota remained perturbed led us to investigate the specific pro-
teins that influenced these global PCA signatures.
We examined the proteins that significantly changed within
mice before, and 1 day after, antibiotic treatment (false discovery
rate [FDR] < 0.05, fold change > 1 ln [natural log]). Although
similar numbers of proteins met these criteria from both antibi-
otic-treatment groups (Figures S2C and S2D), only six (12.5%)
overlapped between datasets: two were more abundant in
both treatments (transthyretin, chymotrypsin-like elastase familyrs
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member 2A); two were downregulated in both treatments
(chymotrypsinogen B, phospholipase A2); and two were down-
regulated in streptomycin-treated mice but were upregulated
in clindamycin-treated mice (myosin-1a, cytochrome c) (Fig-
ure S2E). Phospholipase A2 has known anti-Gram-positive ac-
tivity (Harwig et al., 1995). Thus, under both treatment conditions
in which Gram-positive Clostridiales levels were low, phospholi-
pase A2 would be expected to be downregulated. Clindamycin
treatment appears to upregulate a variety of peptidases, as
well as proteins involved in actin polymerization. Meanwhile,
streptomycin treatment significantly upregulated immunoglob-
ulin-related proteins (i.e., immunoglobulin heavy-chain [IGH]
and immunoglobulin kappa locus [IGK]) (p = 8e-3) while
decreasing the abundance of proteins involved in T cell activa-
tion (DPP4, PIP homolog). Collectively, these data clearly reveal
that different antibiotics have distinct, multi-faceted effects on
the host intestine. These effects manifest on timescales that
correspond with vulnerability to intestinal pathogens.
Dual Host-Microbiota Analyses Identify Unique
Signatures of Pathogen-Induced Inflammatory States
Given the clear effects that antibiotics have on both the micro-
biota and host, we set out to measure the extent to which path-
ogens further derange the commensal microbiota as well as host
protein expression. Mice treated with antibiotics or vehicle con-
trol were subsequently infected with or without pathogen via in-
tragastric gavage (Figure 2A). In both C. difficle and Salmonella
treatment groups, mice that were administered antibiotics prior
to infection experienced a bloom in the abundance of the
respective pathogen. Conversely, pathogen loads remained
below detection levels in mice that were inoculated with either
pathogen without prior antibiotic treatment, as measured by
qPCR (Figures S3A and S3B). Relatively few commensal micro-
bial taxa demonstrated altered abundances in mice inoculated
with Salmonella without streptomycin (Figures 2B and S3C;
Table S2), whereas no significant changes were evident in
mice exposed to C. difficile without prior clindamycin treatment
(data not shown). To further test whether these pathogens were
able to colonize recipient mice in the absence of prior antibiotic
treatment, we performed selective plating from the same stool
specimens used in parallel microbe enumeration and proteomic
assays. These experiments confirmed extremely low-level Sal-
monella infection (<104 colony-forming units [CFU] per gram) in
mice exposed to the pathogen without antibiotics. No such
signal was detected in negative controls or antibiotic-free ani-
mals infected with C. difficile.Figure 1. Antibiotic Treatment Elicits Distinct Effects on the Host and
(A) Conventional mice were dosed with one of two antibiotic treatments: strepto
clindamycin. Antibiotic- and vehicle-treated mice were followed for 4 days, and sto
(B) Alpha diversity at each time point (mean ±SEM)measured by the PD_whole_tre
mice from the streptomycin experiment, whereas Conventional (2) refers to the c
(C) OTUs that are significantly affected by antibiotic treatment, grouped by microb
their respective fold changes (natural log, LN) when comparing a particular tim
significantly changed OTU at any time point was plotted as a colored line individua
points. Black lines represent the median value of OTU fold changes that significa
(D and E) Principal-component analysis was conducted on all 1,425 host proteins
iments and plotted by time point. Diminishing numbers of mice exist because mice
See also Figure S2 and Tables S1, S6, and S7.
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crobiota that differed from antibiotic-only-treated mice at the
same time point. Specifically, whereas streptomycin treatment
promoted increases in the Lachnospiraceae andBacteroidaceae
relative abundances (7-fold and 9-fold, respectively; Figure 1C;
Table S1), the expansion of these taxa was abrogated by Salmo-
nella infection. Alternatively, Enterobacteriaceae family mem-
bers were increased in mice with antibiotic-associated infection,
ranging from 7- to 367-fold increases (Figure 1B). These data
suggest that members of this family, which includes Salmonella,
may benefit from niches Salmonellamade available as the path-
ogen achieved greater abundances and induced severe disease,
as seen in previous studies (Stecher et al., 2007). These data
confirm that discrete signatures of microbiota dysbiosis depend
on the levels at which a pathogen colonizes the host.
Considering that Salmonella exposure with and without prior
antibiotic treatment induced measurable changes to the micro-
biota, we investigated whether the same specific microbial taxa
responded to these two experimental perturbations and found
substantial differences between them. Notably, members of the
Clostridales increased in abundance by 5.7-fold in mice infected
with Salmonella without streptomycin, whereas they decreased
in abundance by 16-foldwith antibiotic-associated infection (Fig-
ure 2B). Similarly, members of the Lactobacillales decreased in
abundance by 12-fold in the mice exposed to Salmonella alone,
whereas they increased by 5.5-fold with antibiotic-associated
infection (Figure 2B). These data further support amodel in which
Salmonella infection with prior antibiotic exposure creates a
distinct perturbation state relative to infectionwithout antibiotics.
The streptomycin-associated Salmonella infection model
used here is particularly severe; the infection becomes systemic,
and mice succumb to the disease around 5 days post-infection.
From the perspective of the host fecal proteome, the antibiotic-
associated Salmonella infection resulted in a highly specific and
easily distinguished state (Figure 2C). We identified 225 proteins
demonstrating significantly changed fecal levels between this
severe perturbation and untreated control mice (Table S3).
Acute-phase inflammatory response proteins were highly repre-
sented among these induced proteins (14 of the 225; Figure 2E)
and included complement C3 and alpha-2-macroglobulin.
Meanwhile, the pancreatic enzymes (chymotrypsin-like elas-
tase, carboxypeptidase B1) that were upregulated in the con-
ventional Salmonella infection were significantly downregulated
during the antibiotic-associated infection.
It should be expected that the severe antibiotic-associated
Salmonella infection model resulted in well-distinguished hostMicrobiota
mycin or a 2-day course of an antibiotic cocktail followed by a single dose of
ol samples were collected for 16S rRNA analysis and host-centric proteomics.
e metric from 16S rRNA sequencing data. Conventional (1) refers to the control
ontrol mice from the clindamycin treatment.
ial family. Briefly, DESeq was used to identify significantly changing OTUs and
e point with the same mice recorded at day 0. For each comparison, each
l point. Zero values are plotted for insignificantly or unchanged OTUs and time
ntly deviated from day-0 levels.
identified across all samples in the (D) streptomycin and (E) clindamycin exper-
were put into different arms of the general experimental paradigm (Figure S1).
rs
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Figure 2. The Effect of Pathogen Infection on the Host and Microbiota
(A) Conventionalmicewere treatedwith antibiotic (as in Figure 1), 1 day prior to infectionwithSalmonella (streptomycin treated) orC. difficile (clindamycin treated).
(B) OTUs from four taxonomic groups that are significantly affected by Salmonella infection, grouped bymicrobial family. DESeq was used to identify significantly
changing OTUs and their respective fold changes when comparing infected mice with the same mice in the starting conventional state. For each comparison,
each significant OTU was plotted as an individual point. The entire list of significantly changing OTUs can be found in Table S2.
(C and D) Principal-component analysis of (C) Salmonella-infected mice and (D) C. difficile-infected mice and the relevant controls at 3 days post-infection.
(E) Cluster analysis of acute-phase inflammation-induced protein abundances, measured from all mice in the Salmonella experiment on day 3 post-infection.
(F) Cluster analysis of protein abundances determined to be significantly changed (FDR < 0.05, > 1 loge fold change) between clindamycin-treated control mice
and clindamycin-treated, C. difficile-infected mice at 3 days post-infection.
See also Figure S3 and Tables S2, S3, S6, and S7.
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protein profiles. However, given that Salmonella numbers were
below the level of qPCR detection in infected mice that did not
receive antibiotics, it would be reasonable to expect that host
proteomic signatures would not be sufficiently sensitive to regis-
ter differences between these animals and untreated controls.
However, by the third day after infection, animals infected with
Salmonella without antibiotics presented protein signatures
distinct from both untreated and antibiotic-treated controls (Fig-
ure 2C). We conclude that host protein profiles were able to
sensitively reflect very slight, pathogen-induced shifts in the in-
testinal microbiome.
As with the microbial taxa described earlier, proteins
measured from the host stool were differentially represented
between mice that were exposed to Salmonella without prior
streptomycin treatment, versus untreated conventional mice
(Figure S3D). For example, 3 days post-infection with Salmo-
nella, antibiotic-free micewere found to have upregulated regen-
erating islet-derived protein 3g (REG3g) and pancreatic protease
expression, whereas aminopeptidase and brush border proteins
were downregulated (p < 0.05; Figure S3D). Furthermore, the
large discrepancy that we measured between the host pro-
teomes of mice inoculated to Salmonella with or without prior
antibiotic treatment suggests completely distinct host responses
to these paradigms of Salmonella infection. Thus, the combina-
tion of both host andmicrobiotameasurements provides a highly
sensitive measure of infection. To further evaluate this approach,
we next investigated the less severe C. difficile infection model
for microbial and proteomic signs of dysbiosis.
Consistent with our microbiota measurements, no global
proteomic changes were evident from mice infected with
C. difficile without clindamycin, providing evidence that, unlike
Salmonella, this pathogen did not colonize the gut in the
absence of antibiotics (Figure 2D). With qPCR, we verified that
C. difficile abundance spikes the first day after antibiotic-asso-
ciated infection and is undetectable 5 days post-infection (Ng
et al., 2013) (Figure S3A). Given the gross pathological impact
of this antibiotic-associated infection (Ng et al., 2013), we ex-
pected to identify a large increase in inflammatory and anti-mi-
crobial proteins commensurate with pathogen levels. We found
increased levels of such proteins from infected mice, including
serotransferrin, complement C3, and REG3g. However, we
were surprised that their observation lagged 2 days behind
emergence of the pathogen perturbation (Figures S3E–S3G).
In total, 48 proteins were significantly changed by the antibi-
otic-associated C. difficile infection on day 3 when compared
to antibiotic-treated controls (Figure 2F). Having defined two
different antibiotic-associated pathogen-induced disease
states from a host protein perspective, we set out to determine
whether the host-centric proteomic profiles we generated were
microbe specific or simply described a continuum of a universal
inflammation response.
Specific and Common Molecular Signatures of Host-
Derived Inflammatory States
To test the microbe specificity of host-centric proteome re-
sponses, we analyzed stool collected from mice experiencing
chemically induced intestinal inflammation. Mice were treated
with dextran sodium sulfate (DSS) for 6 days (4% in drinking wa-1054 Cell Reports 14, 1049–1061, February 9, 2016 ª2016 The Authoter) and then allowed to recover for 8 days with normal drinking
water (Figure 3A). These conditions have been widely used to
model chronic colitis (Cooper et al., 1993). Fecal samples were
collected prior to treatment and at the end of recovery; 85 pro-
teins were found to significantly differ in their abundances
when the two states were compared (Table S4).
Protein levels measured at the height of all three inflammation
states were compared to protein levels measured from the same
mice at the starting conventional state using QSpec (Choi et al.,
2008). The resulting values were filtered to include only proteins
that significantly (FDR < 0.05) changed by at least 1 nl. The Sal-
monella infection was the most substantial perturbation, result-
ing in the greatest number of differentially represented proteins
(Figure 3B). The proteins induced across all three inflammation
models included many acute-phase response proteins, known
to be general markers of inflammation. Only three proteins signif-
icantly decreased in all three types of inflammation; all were
associated with pancreatic enzymes (colipase, chymotrypsin-
C, phospholipase A2). The greatest overlap between any two in-
flammatory states was observed between Salmonella and DSS,
which included the induction of several other acute-phase
response proteins and decreased representation of other
pancreatic enzymes (Figure 3B). Many of these proteins were
similarly regulated in C. difficile-mediated inflammation but did
not achieve statistical significance. Likewise, the decrease in
the abundance of pancreatic enzymes across all three inflamma-
tory states is consistent with diminished pancreatic function
seen in patients suffering from inflammatory bowel disease
(Angelini et al., 1988). These data suggest that host-centric pro-
teomics reflects overall disease severity, showing greater simi-
larities between Salmonella and DSS as compared to C. difficile.
Host-centric proteomics also linked the two microbial inflam-
mation models. All three members of the REG3 family of anti-mi-
crobial, c-type lectins were identified from Salmonella and
C. difficile infections, and not DSS (Figure 3B). These peptides
are produced in response to Toll-like receptor stimulation by
pathogen-associated molecular patterns (Abreu, 2010). Eigh-
teen proteins were significantly regulated in two or more condi-
tions but in alternate directions (Figure 3C). These proteins are
particularly interesting from a diagnostic perspective, as they
most greatly distinguish the inflammatory states considered
here.
The proteins we identified as being shared across two or
more of the experimental models examined here were signifi-
cantly less than expected (p < 5e-22, chi-square test; Figure 3B).
This observation supports the notion that, while ‘‘core’’ inflam-
mation response proteins can be found in the host fecal prote-
ome, they are, nevertheless, a minor component. The majority
of inflammation-induced proteins we found were restricted to
only one experimental condition. These findings suggest that
host-centric proteomic profiles can sensitively distinguish multi-
ple inflammatory conditions in the gut. Salmonella infection
uniquely upregulated proteins related to pigment granules and
cell death, supporting the induction of apoptosis pathways
(Walker et al., 1988). Meanwhile, DSS-induced inflammation
led to increased high-density lipoproteins, which were shown
to have anti-inflammatory effects in colitis models (De Nardo
et al., 2014).rs
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Figure 3. Host Proteins Differentiate Inflammatory Conditions
(A) Experimental model for DSS colitis. Mice were treated with 4% DSS in drinking water for 6 days followed by 8 days on normal drinking water. Samples were
taken prior to and at the end of the experiment.
(B) Venn diagram comparing the proteins significantly different (FDR < 0.05, > 1 ln fold change) in abundance when comparing the peak of inflammation with the
samemice at their original conventional state. Green indicates upregulated in inflammation, Blue indicates downregulated in inflammation. The degree of overlap
in proteins differentially represented between any two conditions, or between all three, was significantly less than would be expected by chance: Salmonella and
C. difficile: p = 3e46; Salmonella and DSS: p = 3e29; C. difficile and DSS: 5e–22; all three: 3e–33 (chi-square test). Expected numbers of overlapping proteins
were calculated from the degree of overlap between all proteins identified in the indicated experimental conditions and the number of proteins found to
significantly change the indicated experimental conditions.
(C) Proteins that were identified as significant in more than one inflammatory condition but that were changing in expression in alternate directions and, therefore,
did not fit in a particular region of the Venn diagram. NS, not significant.
See also Tables S4 and S6.Fecal Transplant Promotes Immediate Host Recovery in
a Microbiota-Independent Manner
Fecal transplants have been shown to induce dramatic and rapid
recovery from dysbiotic states, notably with respect to recalci-Cell RtrantC. difficile infections (Brandt et al., 2012). Work with defined
microbial communities suggest that these benefits are derived
by changing community structure (Lawley et al., 2012), but the
extent to which the host might also mediate a response to theeports 14, 1049–1061, February 9, 2016 ª2016 The Authors 1055
transplant is not well understood. Given the severity of the anti-
biotic and inflammatory perturbations we have described thus
far, we expected that recovery profiles of the host and micro-
biota would be linked over time and that a fecal transplant could
speed the rates at which both recover. Because antibiotic-asso-
ciated Salmonella infections were terminal, transient C. difficile
infections gave us the opportunity to measure recovery dy-
namics over longer, 24-day time courses and to further under-
stand the persistent distortion to the host proteomewe observed
3 days after clindamycin treatment—even without subsequent
C. difficile infection (Figure 2D). C. difficile-infected mice were
treated with a fecal transplant or PBS-control gavage 5 days
post-infection and then monitored for 19 days. These mice
were compared to similarly treated animals that received antibi-
otics without subsequent C. difficile inoculation (Figure 4A).
Prior to receiving fecal transplants on day 5 following
C. difficile infection, microbiota diversity of all clindamycin-
treated mice had begun to approach that of conventional mice
but was still significantly lower (p < 0.05). Interestingly, neither
the prior C. difficile infection nor the subsequent fecal transplant
had a noticeable effect on the microbiota diversity: all four
groups exhibited similar recovery profiles (Figure 4B). By the
11th day following fecal transplant, the microbiota diversity of
all four groups had recovered to a point at which they were
indistinguishable from conventional mice (p > 0.05) (Figure 4B),
but, importantly, several OTUs remained perturbed (Figure S4;
Table S5).
The dynamics of the host proteome were found to contrast
sharply with microbiota recovery profiles. The host remained in
a perturbed state (distinguishable by the first two principal com-
ponents) through day 5 post-infection. Remarkably, just 1 day
after fecal transplant in both conditions (clindamycin with or
without C. difficile), all host proteomes returned to a state indis-
tinguishable from that of conventional, untreated animals (Fig-
ure 4C). Notably, uninfected mice that received fecal transplants
exhibited a spike in anti-microbial protein REG3g at this early
time point, whereas we did not observe a similar, concurrent
spike after fecal transplant in the infected mice. We did, how-
ever, note a pronounced REG3g induction immediately after
the C. difficile inoculation (Figure 4D; Table S6).
These immediate responses to fecal transplant led us to ask
whether the gut proteomes of the remaining perturbed mice
would ever return to the unperturbed state. The proteome of
C. difficile-infected mice that did not receive fecal transplant re-
turned to a conventional state by the 16th day post-infection.
Consistent with prior observations (Buffie et al., 2012), antibi-
otic-treated mice that never received fecal transplants or
C. difficile remained perturbed at all recorded time points until
the end of the experiment, 25 days after antibiotic treatment (Fig-
ure 4C). By contrast, the two treatments that promoted eventual
normalization (fecal transplant or C. difficile infection; Figure 4C)
were preceded by a transient but robust inflammatory response,
marked by a spike in REG3g abundance. No such induction was
observed in the antibiotic-only treatment group (Figure 4D).
Further comparisons between these recovered and non-recov-
ered states could provide insight into the processes required
for re-establishing baseline homeostasis. Toward this end, we
identified a small set of proteolytic enzymes that discriminated1056 Cell Reports 14, 1049–1061, February 9, 2016 ª2016 The Authobetween them (Figure 4E). Three of the seven downregulated
proteins in this group have, or are associated with, trypsin-like
protease activity, while many of the upregulated proteins have
elastase or chymotrypsin activity. This suggested to us that the
repertoire of host-secreted proteolytic enzymes could contribute
to re-establishing a stable microbiota or at least be further diag-
nostic of its perturbation.
Lastly, we sought to identify specific host-microbe interac-
tions that may help to describe the unique dynamics of this re-
covery. We sought specific microbes or proteins that exhibited
the same dynamics as seen in the proteome-wide analyses: spe-
cifically, (1) a return to a conventional state by day 6 post-infec-
tion (day 1 post-fecal transplant) for mice that received a fecal
transplant; (2) a return to a conventional state by day 16 post-
infection for infected mice not given a fecal transplant; and (3)
no observed recovery for antibiotic-treated mice (Figure 4F).
Angiotensin-converting enzyme 2 and an unclassified OTU
from the order Bacteroidales matched these dynamics (Fig-
ure 4G). Of similar interest was a member of the Bacteroides,
which did not appear to have a measurable effect on the host
but appeared to be permanently excluded from recovery in the
un-treated C. difficile infection (Figure S5; Table S7). Thus, our
data suggest a connection between specific microbes with spe-
cific host responses through combined, untargeted microbiota
and host proteome analyses.
DISCUSSION
Antibiotic-associated infections are commonly understood to
arise from the outgrowth of pathogenic microbes into newly
vacated ecological niches within the GI tract. While the gross ef-
fect of these types of infection—intestinal inflammation—involve
the induction of host response pathways, the variety of ways in
which pro-inflammatory states are initially recognized by the
host and the routes by which, and extent to which, healthy states
are restored are poorly understood. They are difficult to infer
from measured shifts in microbial populations alone and may
be impractical tomeasure directly from intestinal tissue biopsies.
Combining microbe enumeration with host-centric proteomics,
as demonstrated here, opens a direct avenue for discriminating
different inflammation states based on molecular and ecological
factors.
We note several surprising outcomes of this multi-omic study.
In the model of Salmonella infection, we observed that strepto-
mycin treatment introduced a clear incongruity between the mi-
crobiota and host proteome (Figures 1B and 1D). One possible
explanation for this observation is that microbial enumeration
by 16S rRNA sequencing is more sensitive than our proteome
assays. However, even though Salmonella remained below the
level of detection of DNA-based assays upon infection without
prior antibiotic treatment (Figure S2), we found a global host
response to Salmonella as measured from the proteome (Fig-
ure 2C). We conclude that, while these assays reflect one
another to some extent (Lichtman et al., 2013), they measure
distinct and complementary aspects of the intestinal micro-
biome; therefore, both are needed. We show here that, at least
in some respects, the host proteome more sensitively reports
nuanced perturbations. For instance, the decrease in thers
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expression of phospholipase A2, a known Gram-positive anti-
bacterial factor, after both antibiotic treatments could be a
response by the host to the depletion of Gram-positive microbes
such as theClostridiales (Harwig et al., 1995).Moreover, the gen-
eral perturbed microbiota state induced by streptomycin alone
initiated far less of a host response than the very low-grade Sal-
monella infection (<104 CFU/g) without antibiotics. This finding
supports the notion that pathogen surveillance within the GI tract
is both highly sensitive and discriminating (Kufer et al., 2006;
Macdonald and Monteleone, 2005).
In the C. difficilemodel, we show that antibiotic treatment pre-
vented the full recovery of the host proteome, even after micro-
biota recovery. Interestingly, recovery of the host correlated with
the abundance of one unclassified family member of the Bacter-
oidales: restoration of both appeared to be dependent on exog-
enous supplementation of the microbiome. Fecal transplant
promoted conventional proteome signatures (Figure 4C) and
levels of this OTU (Figure 4G) just 1 day after administration
(with or without prior C. difficile exposure). C. difficile exposure
without subsequent fecal transplant was also sufficient for
restoring both proteome and this OTU to conventional states,
but in a delayed fashion: Both were synchronized in their recov-
ery by day 16 following pathogen exposure. Without the use of
both microbiota and host-focused analyses, these dynamics
would remain undetected.
Lastly, we were able to further demonstrate the utility of the
host-centric method by identifying proteins that uniquely differ-
entiated inflammatory states from Salmonella, C. difficile, and a
chemically induced model of chronic colitis. This experiment
was important in demonstrating that inflammation alone was
insufficient for producing many of the antimicrobial responses
observed under both Salmonella and C. difficile models. The
identification of upregulatedReg3 proteins only under these con-
ditions is strong evidence that this method accurately reports
host responses to pathogens rather than non-specific signs of
inflammation-induced exposure to otherwise commensal mi-
crobes. The general decrease in pancreatic enzymes such as
transthyretin and chymotrypsin-like elastase (Figure S2) during
all three types of inflammation could indicate amicrobiota-based
effect on pancreatic function. In support of this notion, themicro-
biota hasbeenpreviously shown tomodulate adaptive and innate
immune system pathways in pancreatic disease. One model of
antibiotic-induced pancreatitis demonstrated that commensal
microbes could contribute to disease symptoms in a NOD1-
dependent fashion (Tsuji et al., 2012). Furthermore, both mouse
models of diabetes (Sun et al., 2015) anddiabetic patients (BrownFigure 4. Fecal Transplant Aids in the Recovery of the Host in a Micro
(A) Clindamycin-treated mice were gavaged with C. difficile or PBS control. Fecal
mice and all were tracked for 19 more days.
(B) Alpha diversity of mice in each treatment group, starting at 2 days prior to fec
(C) Principal-component analysis of host proteins, plotted by time point.
(D) Expression profile of REG3g throughout the course of the entire experiment (
(E) Cluster analysis of the proteins that significantly differentiate the antibiotic-t
treatment group as indicated in (C).
(F) Model of host recovery as described by the principal-component analysis.
(G) Expression profile of angiotensin-converting enzyme 2 (normalized spectra
throughout the course of the experiment (mean ± SEM).
See also Figures S4 and S5 and Tables S5, S6, and S7.
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atic output in response to lower levels of butyrate-producing
microbes. Extending the untargeted, host-centric proteomic
analysis presented here to a broader array of experimental con-
ditions in mice and humans stands to better define the dynamic
interactions between microbes and the pancreas in maintaining
intestinal homeostasis or promoting disease.
Host-centric proteomics greatly impacts our understanding of
the clinically meaningful diseases studied here. Previously, we
did not know that antibiotic treatments could have such lasting
effects on the host, beyond the recovery of the microbiota, nor
did we know that fecal transplantation could have microbiota-in-
dependent host effects.
This work highlights the importance of non-invasive, time-
course studies of the gut microbiota. Litter and cage effects
that could otherwise derail such an unbiased ‘‘omics’’-based
investigation are evident in the results but mitigated by tracking
individual mice over the course of an experiment. Comparing a
perturbed state to a conventional state of the same mice dimin-
ishes the biological variability and emphasizes the proteins ormi-
crobes most important to that particular state. Conducting both
of these analyses from the same fecal pellet also aids in elimi-
nating known temporal variability (Costello et al., 2009).
We envision that the host-microbiota-monitoring approach
described here can be further optimized in several ways. Since
next-generation sequencingandmass spectrometry areconcen-
tration-dependent techniques, anybiases towardmoreabundant
species or proteinswill bemitigated as thesemethods’ sensitivity
continue to improve. Likewise, improvements to the quantitative
accuracy of both methods will enhance the ability to distinguish
small but meaningful changes in abundance. Nevertheless, sta-
tistical methodologies have been developed to address current
challenges these types of data (Anders and Huber, 2010; Choi
et al., 2008); the results presented here speak to the utility of
combining these two methods. We also recognize the utility of
these data in answering many questions that we have not pur-
sued and, therefore, have made the data publicly available.
These host-based inflammatory fingerprints have obvious util-
ity for the diagnosis of GI diseases in clinical settings. By extend-
ing the methods we have demonstrated in mouse models to
patients, we expect that host-centric proteomics of stool will
open new insights into the myriad microbial, dietary, genetic,
and environmental triggers of inflammatory conditions in the
gut. Disease-specific proteins identified with this approach can
be further applied toward developing targeted therapeutics
and companion diagnostics to these specific causes. Becausebiota-Independent Fashion
transplants from conventional mice were given to both infected and uninfected
al transplant as measured by the PD_whole_tree metric (mean ± SEM).
mean ± SEM).
reated mice at day 24 from the rest. Symbols under the column refer to the
l counts) and an OTU from the Bacteroidales (normalized OTU read counts)
rs
these analyses are untargeted, the approach we describe here
can extend beyond innate inflammation to includemetabolic dis-
eases, obesity, and cancer.
Multi-omic, non-invasive, time-course experiments become
even more critical as studies move to include human patients
for whom biological variability increases and individuals are
limited. These techniques, combined with the exciting develop-
ments in metabolomics, will enable new dimensions for under-
standing of the complex ecosystem that exists in our GI tract.
It is only with this understanding that we will succeed in devel-
oping novel therapeutics and diagnostics for the growing num-
ber of microbiota-associated diseases.
EXPERIMENTAL PROCEDURES
Mouse Husbandry
All experiments were conducted according to the Administrative Panel on Lab-
oratory Animal Care (A-PLAC), the Stanford University Institutional Animal
Care and Use Committee (IACUC).
Salmonella typhimurium Model
Conventionally raised, female, Swiss-Webster mice (6–10 weeks old) were
separated into four cages of four mice each, and tails were marked to identify
each mouse. Two groups of mice were administered 20 mg streptomycin by
oral gavage, while the other two groups received vehicle control. After 24 hr,
one group of streptomycin-treated mice and one group of untreated mice
received 108 CFUs/ml Salmonella typhimurium via oral gavage from overnight
cultures.Micewere separated into different isolators dependent onSalmonella
status in order to prevent accidental contamination. Mice were monitored for
3 days post-infection and sacrificed on day 3 when antibiotic+/Salmonella+
mice became too sick. Fecal samples were taken before antibiotic treatment,
before Salmonella administration, and at days 1 and 3 post-infection. See also
Figure S1 for the treatment timeline.
Clostridium difficile Model
Conventionally raised,male, Swiss-Webstermice (6–10weeks old) were sepa-
rated into six cages of three mice each, and tails were marked to identify each
mouse. Four groups received an antibiotic cocktail in their water consisting of
kanamycin (0.4 g/l), gentamycin (0.035 g/l), colistin (0.057 g/l), metronidazole
(0.215 g/l), and vancomycin (0.045 g/l) for 2 days. Thesemicewere then placed
back onto normal water for 2 days prior to a single dose of 1 mg clindamycin
via oral gavage. 24 hr post-clindamycin treatment, two groups of antibiotic-
treated mice and one group of untreated mice were administered 108 CFUs
ofClostridium difficile via oral gavage from overnight cultures.Micewere sepa-
rated into isolators based on C. difficile status in order to prevent cross-
contamination by pathogen spores. 5 days post-infection, fecal transplants
were conducted on mice from two groups, antibiotic+/C. difficile+ and antibi-
otic+/C. difficile. Fecal samples from the fully conventional mice were taken
fresh and suspended in PBS, and 200 ml were administered via oral gavage.
Fecal samples were collected from all mice prior to antibiotic cocktail, prior
to clindamycin treatment, prior to infection, and at days 1, 3, 5 (day of fecal
transplant), 6, 7, 10, 16, and 24 post-infection. All mice were sacrificed on
day 24 post-infection. See also Figure S1 for the treatment timeline.
DSS Inflammation Model
In order to obtain a chronic inflammation that has been compared to inflamma-
tory bowel disease, mice were treated with DSS over several days and then al-
lowed to recover.While they recoveredphysically, chronicGI inflammation per-
sisted. Five conventionally raised, Swiss-Webstermicewere put onto 4% (w/v)
DSS in their drinking water for 6 days, and their weight was monitored daily.
Twomice (with thegreatest and leastweight loss)were sacrificed, and theother
three mice were placed back onto drinking water. Weight was measured daily
for 8 additional days, as mice recovered from an acute colitis to amore chronic
one.Micewere tracked via tailmark, and fecal sampleswere takenat thebegin-Cell Rning and end of the experiment. Due to the traumatic nature of the DSS treat-
ment, collecting fecal sampleswas not possible during the acute inflammation.
Host-centric Proteomics
We conducted fecal proteomics as previously described (Lichtman et al.,
2013), with the following notable changes. Instead of analyzing all four fractions
(20%, 40%, 60%, and 100% acetonitrile) from the C4 solid-phase extraction
chromatography, only the 40% and 60% fractions were digested and
analyzed. Each sample was only analyzed with no technical replicates on an
LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific). Furthermore, the
msConvert program (v3.0.45) was used to generate peak lists from the original
data, and spectra were assigned to peptides using the SEQUEST (v28.12) (Eng
et al., 1994) algorithm. Spectra were queried against a composite ‘‘target-
decoy’’ sequence database consisting of themouse proteome (UniProt, down-
loadedOctober 30, 2012) and reversed decoy versions of the same sequences
(Elias and Gygi, 2007). SEQUEST search parameters included using a semi-
specific enzyme specificity, 50 ppm precursor mass tolerance, 1-Da fragment
ion mass tolerance, static carbamidomethylation of cysteines, differential
oxidation of methionines, and differential deamidation of glutamines and as-
paragines. Each mass spectrometry run was filtered to a 1% peptide FDR,
and the experiment-wide FDR was filtered to 5% using a linear discriminant
analysis (Huttlin et al., 2010). All raw data are available on the PRIDE repository
(Vizcaı´no et al., 2013), with the dataset identifiers PXD003152, PXD003167,
PXD003168, PXD003169, PXD003170, and PXD003171.
Spectral counts were normalized as a percentage of the total counts for a
given fecal sample. Fold changes and statistical tests were performed using
the QSpec software package (Choi et al., 2008). Centroid clustering was con-
ducted on normalized spectral counts after normalizing to the abundance of
each protein using Cluster (v3.0) and visualized using Treeview (v1.1.6r4). Prin-
cipal-component analysis was conducted on normalized spectral counts using
the princomp function in MATLAB (v2012a). Proteins were identified as part of
particular pathways using Ingenuity Pathway Analysis, and Gene Ontology en-
richments were calculated with DAVID (Huang et al., 2009a, 2009b).
16S rRNA Microbial Community Profiling
Fecal DNA was isolated (MoBio PowerFecal Kit) from 1 ml of stool, and ampli-
cons of the V4 region of the bacterial 16S rRNA gene were made using bar-
coded forward primers (515f, 806R). Samples were sequenced at the Medical
Genome Facility, Mayo Clinic, using the MiSeq platform (Illumina). Sequence
quality was evaluated with FastQC (http://www.bioinformatics.babraham.ac.
uk/projects/fastqc/), and a dynamic trimmer (Cox et al., 2010) was used to re-
move segments of sequences of poorer quality. Paired-ends were then joined
using fastq-join (Aronesty, 2013) and de-multiplexed using QIIME (Caporaso
et al., 2010). OTUswere picked against the Greengenes 13.8 release database
(http://greengenes.secondgenome.com), using a 97% similarity threshold. In
order to capture novel sequences, those sequences that would not cluster
were clustered de novo. OTUs were considered if they were represented by
at least 0.001% of all sequences (Caporaso et al., 2011). Raw sequence
data are available upon request.
Alpha diversity was calculated with QIIME (Qualitative Insights intoMicrobial
Energy) using the PD_whole_tree method. For significance testing, OTUs were
removed if they were not present with at least three counts across at least four
individual samples. Significance testing was conducted using DESeq software
(v1.4.5) (Anders and Huber, 2010) in R (v3.1.1) and filtered to an adjusted
p value of <0.01.
qPCR
Total genomic DNA, extracted as described earlier, was diluted to 5 ng/ml by
picoGreen assay. Primers to the Salmonella typhimurium ttrA gene and the
Clostridium difficile CD2344 gene were used to assay microbial abundance
via real-time qPCR.
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